NCT05336669|Unknown
Coagulation Profile in Patients Undergoing Coronary Angiography and Percutaneous Coronary Intervention
GlobalACT
Loading search results
GlobalACT
Sponsor study identifier
observational
40
0 countries
N/A
Study Start
April 30, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
August 31, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 31, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The activated clotting time (ACT), global thrombosis test (GTT-3), platelet inhibition P2Y12 (VerifyNow) test and serum coagulation factors will be measured in patients undergoing coronary angiography (CA) and percutaneous coronary intervention (PCI).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 31, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 24, 2021
Actual (reported)April 20, 2022
Actual (reported)April 30, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
August 31, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
August 31, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
ACT change
Activated Clotting Time
Baseline ACT , 10 minutes ACT, 2 hours ACT, 6 hours ACT, 30 days ACT
GTT-3 change
Global Thrombosis Test
Baseline GTT-3, 10 minutes GTT-3, 2 hours GTT-3, 6 hours GTT-3, 30 days ACT
VerifyNow change
Platelet inhibition P2Y12 test
Baseline VerifyNow, 10 minutes VerifyNow, 2 hours VerifyNow, 6 hours VerifyNow, 30 days ACT
Non-smoking patients undergoing coronary angiography or percutaneous coronary intervention
Smoking patients undergoing coronary angiography or percutaneous coronary intervention
40 patients, 20 smoking at least 10 cigarettes a day, 20 patients non-smoking (\<1 cigarette in last 30 days)
Ramotowski B, Lewandowski P, Slomski T, Maciejewski P, Budaj A. Platelet reactivity and activated clotting time predict hemorrhagic site complications in patients with chronic coronary syndromes undergoing percutaneous coronary interventions. Coron Artery Dis. 2024 Jun 1;35(4):292-298. doi: 10.1097/MCA.0000000000001336. Epub 2024 Jan 22.
2ml sample of full blood from each patient at baseline 4ml sample of plasma from each patient at each timepoint
Bogumił Ramotowski
Centre of Postgraduate Medical Education
First Submitted
September 24, 2021
First Posted
April 20, 2022
Study Start
April 30, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
August 31, 2022
Estimated (date passed)Integrating Financial Coaching and Smoking Cessation Coaching
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 31, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
April 20, 2022
Record last verified: 2021-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: